W T Jackson - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

W T Jackson

Showing results (151-160 of 153) with videos related to

Pageof 16

Sort By:

You have reached the last page of results.This site can display upto 153 results.

The Journal of Pharmacology and Experimental Therapeutics|December 23, 1998

Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studiesW T Jackson, L L Froelich, R J Boyd, et al.

Advances in Experimental Medicine and Biology|January 1, 1997

The discovery of LY293111, a novel, potent and orally active leukotriene B4 receptor antagonist of the biphenylphenol classM J Sofia, P Floreancig, N Bach, et al.

Nature Communications|March 16, 2024

Coastal shoreline change assessments at global scalesJonathan A Warrick, Daniel Buscombe, Kilian Vos, et al.

Pageof 16

Search research articles

Showing results (151-160 of 153) with videos related to

Sort By:

Pageof 16

You have reached the last page of results.This site can display upto 153 results.

The Journal of Pharmacology and Experimental Therapeutics|December 23, 1998

Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studiesW T Jackson, L L Froelich, R J Boyd, et al.

Advances in Experimental Medicine and Biology|January 1, 1997

The discovery of LY293111, a novel, potent and orally active leukotriene B4 receptor antagonist of the biphenylphenol classM J Sofia, P Floreancig, N Bach, et al.

Nature Communications|March 16, 2024

Coastal shoreline change assessments at global scalesJonathan A Warrick, Daniel Buscombe, Kilian Vos, et al.

Pageof 16